BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukuda Y, Homma T, Inoue H, Goto Y, Sato Y, Ikeda H, Onitsuka C, Sato H, Akimoto K, Ebato T, Suganuma H, Kawahara T, Mikuni H, Uchida Y, Suzuki S, Tanaka A, Sagara H. Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19. Sci Rep 2022;12:5458. [PMID: 35361913 DOI: 10.1038/s41598-022-09544-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sorrentino L, Fracella M, Frasca F, D’auria A, Santinelli L, Maddaloni L, Bugani G, Bitossi C, Gentile M, Ceccarelli G, Turriziani O, Mastroianni CM, Antonelli G, d’Ettorre G, Pierangeli A, Scagnolari C. Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients. Microorganisms 2023;11:689. [DOI: 10.3390/microorganisms11030689] [Reference Citation Analysis]
2 Brown B, Ojha V, Fricke I, Al-Sheboul SA, Imarogbe C, Gravier T, Green M, Peterson L, Koutsaroff IP, Demir A, Andrieu J, Leow CY, Leow CH. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. Vaccines (Basel) 2023;11. [PMID: 36851285 DOI: 10.3390/vaccines11020408] [Reference Citation Analysis]
3 Wu JL, Kuan II, Guo JY, Hsu WC, Tang WC, Chan HJ, Chen YJ, Chen BC, Wu HC, Liao JC. SARS-CoV-2 N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron. iScience 2023;26:105995. [PMID: 36687314 DOI: 10.1016/j.isci.2023.105995] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zandi M, Shafaati M, Kalantar-Neyestanaki D, Pourghadamyari H, Fani M, Soltani S, Kaleji H, Abbasi S. The role of SARS-CoV-2 accessory proteins in immune evasion. Biomed Pharmacother 2022;156:113889. [PMID: 36265309 DOI: 10.1016/j.biopha.2022.113889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Znaidia M, Demeret C, van der Werf S, Komarova AV. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. Viruses 2022;14:1247. [PMID: 35746718 DOI: 10.3390/v14061247] [Cited by in F6Publishing: 2] [Reference Citation Analysis]